Zentiva expands production capacity by acquiring Sanofi Ankleshwar plant

▴ zentiva-expands-production-capacity-meets-european-market-demands
Zentiva expands production capacity by completing acquisition of Ankleshwar manufacturing site from Sanofi

Zentiva Group announces the completion of its acquisition of a manufacturing site in Ankleshwar, India, from Sanofi. The finalization of the deal increases the number of wholly-owned Zentiva production sites worldwide and will enable Zentiva to serve more people who are in daily need of our high quality, affordable medicines.

"We are delighted to welcome the Ankleshwar team into our Zentiva family. We are continuing to deliver strong growth at Zentiva and the completion of this acquisition is an important milestone for our company," said Nick Haggar, Chief Executive Officer of Zentiva. "The strength of our growing manufacturing network and additional capacity means we can keep pace with the accelerating demand for our medicines and increase our direct control over our supply chain to help ensure continuous supply and rapid response to patient needs."

The transaction continues the flow of decisive growth moves made by Zentiva, building on earlier acquisitions of Creo Pharma in the UK, Solacium in Romania and the Central and Eastern European operations of Alvogen completed in April 2020. This latest acquisition in India runs in parallel to the ongoing multiple multi-million Euro investments at Zentiva's flagship sites in Prague and Bucharest.

"I am so proud that our Ankleshwar team will be part of an even stronger Zentiva, integrated into the organization's long-term growth strategy," added Ashwani Sood, Head of the Ankleshwar site. "We know demand for high quality and affordable medicines is increasing and we look forward to contributing to Zentiva's success on this journey."

The manufacturing site will be supported by a brand new Zentiva India affiliate office in Mumbai.

Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,700 people and a network of production sites - including flagship sites in Prague, Bucharest and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people's daily healthcare needs.

At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on.

Tags : #ZentivaGroup #Sanofi #AshwaniSood #NickHaggar

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Global Coronavirus deaths cross 1 Million markSeptember 28, 2020
Navigation system and Robotics amongst the new trends in spine surgery says Dr. G Amrit, Orthopedic Spine Surgeon  September 28, 2020
WISI Meetings: Sports Management (India)September 28, 2020
Indoco Remedies launches FEVINDO : 400 mg FavipiravirSeptember 28, 2020
Myanmar extends COVID-19 lockdown in 11 new areas ; International flights suspended till Oct 31September 28, 2020
Nagaland, Manipur Covid-19 News Update Sep 28, 2020September 28, 2020
Delhi reports 3,292 fresh cases of COVID-19 , Himachal Pradesh 195September 28, 2020
9543 people test positive for new Covid-19 cases in KarnatakaSeptember 28, 2020
Zymo Research granted CE IVD Mark for sample collection devicesSeptember 28, 2020
India COVID-19 News update Date across States and UT's - September 27 , 2020September 27, 2020
VAXART investigation initiated by former Louisiana Attorney GeneralSeptember 26, 2020
Bangladesh prepares for ‘second wave’ as Corona death crosses 5,000 markSeptember 26, 2020
Thane district in Maharashtra recorded 1,671 new cases of COVID-19September 26, 2020
NPPA decides to cap price of liquid medical oxygen & medical oxygen cylindersSeptember 26, 2020
Mesothelioma September 26, 2020
Highly effective antibodies identified, may lead to passive COVID-19 vaccineSeptember 26, 2020
Europe has a lot of work to do to prevent COVID-19 transmission: WHOSeptember 26, 2020
Some severe COVID-19 cases linked to genetic mutationsSeptember 26, 2020
Two million Coronavirus deaths : WHO September 26, 2020
Johnson & Johnson COVID-19 vaccine produces strong results September 26, 2020